Публикации
2024 |
1. Rakhmatullina, A.R.; Zolotykh, M.A.; Filina, Y.V.; Valiullina, A.K.; Zmievskaya, E.A.; Gafurbaeva, D.U.; Sagdeeva, A.R.; Bulatov, E.R.; Rizvanov, A.A.; Miftakhova, R.R. Multicellular Cancer-Stroma Spheres (CSS) for In Vitro Assessment of CAR-T Cell-Associated Toxicity. Cells (2024). DOI:10.3390/cells13221892, WoS/Scopus, IF= 5.1, Q1; |
2. Woodcock, C. L., Alsaleem, M., Toss, M. S., Lothion-Roy, J., Harris, A. E., Jeyapalan, J. N., Blatt, N., Rizvanov, A. A., Miftakhova, R. R., Kariri, Y. A., Madhusudan, S., Green, A. R., Rutland, C. S., Fray, R. G., Rakha, E. A., & Mongan, N. P. The role of the ALKBH5 RNA demethylase in invasive breast cancer Discover Oncology (2024), DOI:10.1007/s12672-024-01205-8, WoS/Scopus, IF= 1.1, Q2; |
3. Filina Y.V., Feyskhanov A.K., Ibragimova A.R., Rizvanov A.A., Miftakhova R.R. Cadherin EGF LAG Seven-Pass G-type Receptor 1 (CELSR1) in Primary Lymphedema Flebologiya (2024), DOI: 10.17116/flebo202418021163. Scopus, IF= 0.2, Q3; |
4. Zolotykh M.A., Mingazova L.A., Filina Y.V., Blatt N.L., Nesterova A. I., Sabirov A.G., Rizvanov A. A., Miftakhova R. R. Cancer of unknown primary and the «seed and soil» hypothesis. Critical Reviews in Oncology/Hematology (2024), DOI: 10.1016/j.critrevonc.2024.104297. WoS/Scopus, IF= 6.6, Q1; |
5. Rakhmatullina A.R., Zolotykh M.A., Filina Y.V., Mingaleeva R.N., Sagdeeva A.R.,. Boulygina E.A, Gafurbaeva D.U., Bulatov E.R., Rizvanov A.A., Miftakhova R.R. Development of a novel prostate Cancer-Stroma Sphere (CSS) model for in vitro tumor microenvironment studies. Transl Oncol. (2024), DOI: 10.1016/j.tranon.2024.101930. WoS/Scopus, IF= 5.0, Q1; |
6. Boldinova E.O., Baranovskiy A.G., Filina YV, Miftakhova RR, Shamsutdinova YF, Tahirov TH, Makarova AV. PrimPol Variant V102A with Altered Primase and Polymerase Activities. J Mol Biol. (2024), DOI:10.1016/j.jmb.2024.168542. WoS/Scopus, IF= 5.6, Q1; |
7. Gabdoulkhakova A.G., Mingaleeva R.N., Romozanova A.M., Sagdeeva A.R., Filina Y.V., Rizvanov A.A., Miftakhova R.R. Immunology of SARS-CoV-2 Infection. Biochemistry Moscow (2024), DOI:10.1134/S0006297924010048. Scopus, IF = 2.85, Q2. |
2023 |
1. Rakhmatullina, A.R.; Mingaleeva, R.N.; Gafurbaeva, D.U.; Glazunova, O.N.; Sagdeeva, A.R.; Bulatov, E.R.; Rizvanov, A.A.; Miftakhova, R.R. Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels. J. Pers. Med. (2023), DOI: 10.3390/jpm13111621. WoS/Scopus, IF= 3,4, Q2; |
2. Pashirova, T.; Shaihutdinova, Z.; Tatarinov, D.; Mansurova, M.; Kazakova, R.; Bogdanov, A.; Chabrière, E.; Jacquet, P.; Daudé, D.; Akhunzianov, A.A.; Miftakhova, R.R.; Masson, P. Tuning the Envelope Structure of Enzyme Nanoreactors for In Vivo Detoxification of Organophosphates. Int. J. Mol. Sci.(2023), DOI: 10.3390/ijms242115756. WoS/Scopus, IF= 5.6, Q1; |
3. Zolotykh M.A, Bilyalov A.I, Nesterova A.I, Gimranov A.M, Filina Y.V, Rizvanov A.A, Miftakhova R.R. Breast cancer: genetic personal risk factors: A review. Journal of Modern Oncology (2023), DOI: 10.26442/18151434.2023.2.202110. Scopus, IF= 0.2, Q4; |
2022
1. Filina Y, Gabdoulkhakova A, Rizvanov A, MAP kinases in regulation of NOX activity stimulated through two types of formyl peptide receptors in murine bone marrow granulocytes//Cellular Signalling. - 2022. - Vol.90, Is.. - Art. №110205. DOI: 10.1016/j.cellsig.2021.110205, WoS/Scopus, IF= 4.4, Q2; |
2. Titov, A.; Kaminskiy, Y.; Ganeeva, I.; Zmievskaya, E.; Valiullina, A.; Rakhmatullina, A.; Petukhov, A.; Miftakhova, R.; Rizvanov, A.; Bulatov, E. Knowns and Unknowns about CAR-T Cell Dysfunction. Cancers (2022), DOI:10.3390/cancers14041078 WoS/Scopus, IF = 6.6, Q1 |
3. Ishmukhametov I, Batasheva S, Rozhina E, DNA/Magnetic Nanoparticles Composite to Attenuate Glass Surface Nanotopography for Enhanced Mesenchymal Stem Cell Differentiation//Polymers. - 2022. - Vol.14, Is.2. - Art. №344. doi.org/10.3390/polym14020344 WoS/Scopus, IF = 4.9, Q1 |
4. Филина, Ю.В. Генетические маркеры первичной ранней лимфедемы / Ю.В. Филина, М.А. Золотых, А.К. Фейсханов, А.А. Ризванов, Р.Р. Мифтахова // Флебология. – 2022. – С. 69-70 |
5. Mingaleeva, R.N., Nigmatulina, N.A., Sharafetdinova, L.M., Romozanova A.M., Gabdoulkhakova A.G., Filina Y.V., Shavaliyev R.F., Rizvanov A.A., Miftakhova R.R. Biology of the SARS-CoV-2 Coronavirus. Biochemistry Moscow (2022), DOI: 10.1134/S0006297922120215. Scopus IF = 2.85, Q2; |
6. Filina Y.V, Tikhonova I.V, Gabdoulkhakova A.G, Mechanisms of ERK phosphorylation triggered via mouse formyl peptide receptor 2//Biochimica et Biophysica Acta - Molecular Cell Research. - 2022. - Vol.1869, Is.12. - Art. №119356. DOI: 10.1016/j.bbamcr.2022.119356 Scopus IF = 4.6, Q1; |
7. Ganeeva, I.; Zmievskaya, E.; Valiullina, A.; Kudriaeva, A.; Miftakhova, R.; Rybalov, A.; Bulatov, E. Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies. Bioengineering, (2022), DOI: 10.3390/bioengineering9120808. WoS/Scopus, IF = 4.86, Q2; |